A Multi-Center Phase Ib Study of Oxaliplatin (NSC 266046) in Combination With Fluorouracil and Leucovorin in Pediatric Patients With Advanced Solid Tumors.
Phase of Trial: Phase I
Latest Information Update: 08 Oct 2015
At a glance
- Drugs Oxaliplatin (Primary) ; Fluorouracil; Folinic acid
- Indications Solid tumours
- Focus Adverse reactions
- 16 Jun 2009 Lead trial centre (National Cancer Institute) added as reported by ClinicalTrials.gov.
- 16 Jun 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Sep 2006 Status change